Anna Djos
6PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 23, 2024
Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis.Torben Ek, Raghda R Ibrahim, Hartmut Vogt
|Jul 20, 2024
Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance.Anna Djos, Johanna Svensson, Jennie Gaarder
|Dec 23, 2023
Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the <i>TERT</i> and <i>ATRX</i> Genes.Anna Djos, Ketan Thombare, Roshan Vaid
|Sep 23, 2022
Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline <i>ALK</i> F1174I Mutation.Anna Djos, Diana Treis, Susanne Fransson
|Jan 27, 2022
Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation.Diana Treis, Ganesh Umapathy, Susanne Fransson
|Nov 30, 2017
MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas.Ganesh Umapathy, Jikui Guan, Dan E Gustafsson
Pageof 1
Frequent Collaborators
5 joint publications
Tommy Martinsson
5 joint publications
Susanne Fransson
4 joint publications
Per Kogner
3 joint publications
Torben Ek
3 joint publications
Ruth H Palmer
3 joint publications
Diana Treis
2 joint publications
Ganesh Umapathy
2 joint publications
Jikui Guan
2 joint publications
Kleopatra Georgantzi
2 joint publications
Bengt Hallberg
